[Tumor-associated trypsin inhibitor--an expanded tumor marker spectrum in cervix cancer?].
Medl
M
M
Gynäkologisch-geburtshilfliche Abteilung Krankenhaus Lainz.
Ogris
E
E
Fuchs
G
G
Leodolter
S
S
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D012016:Reference Values; D014361:Trypsin Inhibitors / Q000097:blood*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000473:pathology
D014408:Biomarkers, Tumor; D014361:Trypsin Inhibitors
TATI--Eine Erweiterung des Tumormarkerspektrums beim Zervixkarzinom?